Effectiveness of Umonium38 against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA)

Effectiveness of Umonium38 against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA)

Abstract Aims We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. Methods and results Umonium38 was diluted to 0.5%, 1...

Full description

Bibliographic Details
Main Authors: Soiratchaneekorn Ruanchaiman, Premjit Amornchai, Vanaporn Wuthiekanun, Sayan Langla, Peerapol Maroongruang, Khanh Kim Le, Stuart D. Blacksell
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Infectious Diseases
Subjects:
Umonium38
Virkon
Bacterial viability
Disinfectant
Online Access:https://doi.org/10.1186/s12879-024-09102-9

Internet

https://doi.org/10.1186/s12879-024-09102-9

Similar Items